106
Views
6
CrossRef citations to date
0
Altmetric
Original Articles

Synthesis and Characterization of New 3,5-DIARYL-3H-Dispiropyran/Thiopyran[4,2′-Chroman-3′,2-[1,3,4-Thiadiazol]-4′-One Derivatives and Related Compounds as Anticancer and Antiviral Agents

, , , , , , & show all
Pages 1901-1911 | Received 03 Dec 2014, Accepted 18 Mar 2015, Published online: 02 Dec 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Tamer El Malah, Ahmed H. Shamroukh, Eman R. Kotb, Hanan A. Soliman, Khaled Mahmoud & Mohamed I. Hegab. (2021) Chemical and anticancer activity studies for some 3-chloro-3-chlorosulfenyl-4′-methylspiro[chroman-2,1′-cyclohexane]-4-ones. Phosphorus, Sulfur, and Silicon and the Related Elements 196:11, pages 970-977.
Read now

Articles from other publishers (5)

M. I. Hegab. (2023) A Review on Chemical and Biological Studies of 4-Chromanone Derivatives. Russian Journal of Organic Chemistry 59:3, pages 483-497.
Crossref
L. A. Baeva, L. F. Biktasheva, R. R. Gataullin & A. A. Fatykhov. (2022) Condensation of 3,5-Dialkyltetrahydro-4H-thiopyran-4-ones with Formaldehyde. Russian Journal of General Chemistry 92:9, pages 1677-1685.
Crossref
Diwan S. Rawat & Girijesh Kumar Verma. 2022. Comprehensive Heterocyclic Chemistry IV. Comprehensive Heterocyclic Chemistry IV 542 585 .
Roger W. Read. 2022. Comprehensive Heterocyclic Chemistry IV. Comprehensive Heterocyclic Chemistry IV 726 795 .
Sonia Kamboj & Randhir Singh. (2021) Chromanone-A Prerogative Therapeutic Scaffold: An Overview. Arabian Journal for Science and Engineering 47:1, pages 75-111.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.